Hemp Biz Group Urges FDA Action On CBD After New Study
The U.S. Hemp Roundtable has again urged the U.S. Food and Drug Administration to begin regulating CBD and other hemp derivatives, pointing to a recently released study it says confirms the...To view the full article, register now.
Already a subscriber? Click here to view full article